Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen

US Patent 5646123 · Granted Jul 8, 1997

Assignee

Inventors

View full patent text on Google Patents →